Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer
Abstract Cytokine-induced killer (CIK) cell therapy is a type of adoptive immunotherapy that due to its high proliferation rate and anti-tumor characteristics, is being investigated to treat various solid tumors. Since advanced colorectal cancer (CRC) has high mortality and poor survival rates, and...
Main Authors: | Farimah Fayyaz, Niloufar Yazdanpanah, Nima Rezaei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-022-00836-0 |
Similar Items
-
Retrospective analysis of the efficacy of cytokine‐induced killer cell immunotherapy combined with first‐line chemotherapy in patients with metastatic colorectal cancer
by: Qiu‐Zhong Pan, et al.
Published: (2020-01-01) -
Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection
by: Qiu-Zhong Pan, et al.
Published: (2020-01-01) -
Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
by: Yunqing Xie, et al.
Published: (2017-11-01) -
Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials
by: Ying Zhang, et al.
Published: (2021-11-01) -
Cytokine Induced Killer (CIK) Cells Based Adoptive Immunotherapy
by: S Timalsena, et al.
Published: (2018-08-01)